Supplementary Figure 1 from Prospective Comprehensive Molecular Characterization of Lung Adenocarcinomas for Efficient Patient Matching to Approved and Emerging Therapies

MLA

Gregory J. Riely, et al. Supplementary Figure 1 from Prospective Comprehensive Molecular Characterization of Lung Adenocarcinomas for Efficient Patient Matching to Approved and Emerging Therapies. Apr. 2023. EBSCOhost, https://doi.org/10.1158/2159-8290.22531753.v1.

APA

Gregory J. Riely, Marc Ladanyi, David B. Solit, Michael F. Berger, David M. Hyman, Charles M. Rudin, Nikolaus Schultz, Barry S. Taylor, José Baselga, Jamie E. Chaft, Mark G. Kris, Valerie W. Rusch, Ryma Benayed, Dalicia N. Reales, Matthew D. Hellmann, Alexander Drilon, Paul K. Paik, Helena A. Yu, Bob T. Li, … Emmet J. Jordan. (2023). Supplementary Figure 1 from Prospective Comprehensive Molecular Characterization of Lung Adenocarcinomas for Efficient Patient Matching to Approved and Emerging Therapies. https://doi.org/10.1158/2159-8290.22531753.v1

Chicago

Gregory J. Riely, Marc Ladanyi, David B. Solit, Michael F. Berger, David M. Hyman, Charles M. Rudin, Nikolaus Schultz, et al. 2023. “Supplementary Figure 1 from Prospective Comprehensive Molecular Characterization of Lung Adenocarcinomas for Efficient Patient Matching to Approved and Emerging Therapies,” April. doi:10.1158/2159-8290.22531753.v1.